scispace - formally typeset
S

Srijata Mukherjee

Researcher at Indian Institute of Chemical Biology

Publications -  5
Citations -  67

Srijata Mukherjee is an academic researcher from Indian Institute of Chemical Biology. The author has contributed to research in topics: Deubiquitinating enzyme & Gene. The author has an hindex of 3, co-authored 4 publications receiving 60 citations.

Papers
More filters
Journal ArticleDOI

SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.

TL;DR: The results presented here for the first time highlight the role of SMAR1 in masking the active phosphorylation site of p53, enabling the deacetylation of p 53 by HDAC1-MDM2 complex, thereby regulating the p53 transcriptional response during stress rescue.
Journal ArticleDOI

Cellobiose dehydrogenase production by the mycelial culture of the mushroom Termitomyces clypeatus

TL;DR: Termitomyces clypeatus produces cellobiose dehydrogenase (CDHtc) in cellulose medium with the highest yield (55.88 U mL−1) among all the reported fungal species and it exhibited a wide range of pH stability from pH 2.0 to 8.0.
Journal ArticleDOI

Conformational Adaptation in the E. coli Sigma 32 Protein in Response to Heat Shock

TL;DR: This study has modeled the E. coli σ(32) structure by homology modeling and conducted extensive molecular dynamics simulations at non-heat-shock (30 °C) and heat-shock temperatures and observed significant structural changes that suggest reduction of DnaK/DnaJ affinity for σ (32) at 42 °C, which is further supported by the molecular docking analysis.
Journal ArticleDOI

Alternative sigma factors in the free state are equilibrium mixtures of open and compact conformations

TL;DR: Free alternative sigma factors may be in equilibrium between two conformations: a compact one in which the promoter interacting motifs are trapped in the wrong conformation and another less abundant one with a more open and flexible conformation.
Journal ArticleDOI

A small HDM2 antagonist peptide and a USP7 inhibitor synergistically inhibit the p53‐HDM2‐USP7 circuit

TL;DR: In this paper , a small helically constrained peptide was developed that potently inhibited p53−HDM2 interaction and exerted anti-proliferative effects on p53+/+ cells.